期刊文献+

血管内皮生长因子在恶性腹水诊断及形成中的作用 被引量:6

Vascular endothelial growth factor in the diagnosis and formation of malignant ascites
原文传递
导出
摘要 目的 探讨血管内皮生长因子 (VEGF)对恶性腹水的诊断价值及其在恶性腹水形成中的作用。方法 收集各种类型腹水及腹腔液 ,采用ELISA法检测VEGF水平。结果 癌性腹水组VEGF水平为 (6 4 0 .7± 2 6 4 .8)pg/ml,明显高于肝硬变腹水组、结核性腹水组及良、恶性疾病不伴腹水患者腹腔液组 (P <0 .0 1) ,而后 4组间比较VEGF水平则无明显差异 (P >0 .0 5 )。不同组织来源恶性腹水中卵巢癌组VEGF水平为 (86 6 .3± 2 0 8.5 )pg/ml,高于胃癌组 (P <0 .0 1)和结肠癌组 (P <0 .0 1) ;胃癌组VEGF水平高于结肠癌组 ,但差异无显著性 (P >0 .0 5 )。以肝硬变腹水作为对照组 ,以其VEGF含量均值上限 118.96pg/ml为阳性界值时 ,诊断恶性腹水的敏感性为 91.3% ,特异性为 88.9%。结论 VEGF对良、恶性腹水的鉴别诊断有重要价值 ,它可能在恶性腹水的形成中起重要作用。 Objective To explore the diagnostic value of vascular endothelial growth factor(VEGF) in malignant ascites and the role in the formation of malignant ascites.Methods VEGF levels from various ascites and fluids of abdominal cavity were detected by enzyme-linked immunosorbent assay(ELISA).Results VEGF levels in malignant ascites were(640.7±264.8) pg/ml,significantly higher than those in cirrhotic ascites,tuberculous ascites,and fluids of abdominal cavity of patients with benign and malignant disease but without ascites(P<0.01).However,there was no remarkable difference in VEGF levels among the latter 4 groups(P>0.05).VEGF levels in malignant ascites from patients with ovarian cancers were (866.3±208.5)pg/ml, higher than those with gastric (P<0.01) and colon cancers(P<0.01),but there was no significant difference in VEGF levels between gastric and colon cancers(P>0.05).Using VEGF levels 118.96 pg/ml as a minimum cutofflimit,the sensitivity and specificity of VEGF of this assay to diagnose ascites were 91.3% and 88.9%,respectively.Conclusion The detection of VEGF levels is useful in differential diagnosis of benign and malignant ascites.VEGF may play an important role in malignant ascites formation.
出处 《中国综合临床》 北大核心 2004年第4期334-336,共3页 Clinical Medicine of China
关键词 腹水 血管内皮生长因子 Ascites Vascular endothelial growth factor
  • 相关文献

参考文献8

  • 1Imoto H, Osakl T, Taga S, et al. Vascular eadothelial growth factor expression iu non-small-cell lung cancer: Prognostic signficance in squamous cell carcinoma[ J ]. J Thoracic Cardiovasc Surdiovasc Surgery,1998,115 (10) :1007-1014.
  • 2Kraft A,Weindel K,Ochs A,et al. Vascular endothelial growth factor in the sera and effusion of patients with malignant and nonmalignant disease[J]. Cancer, 1999,85(1 ) :178-187.
  • 3Mori A,Arii S, Furutani M, et al. Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes[ J ]. Gene Therapy,2000,7(12): 1027-1033.
  • 4Zebrowski BK,Liu W,Ramirez K,et al. Markedly elevated levels of vascular endothelial growth factor in malignant ascites[ J]. Ann Sury Onco1,1999,6 (4) :373-378.
  • 5Stoelcker B,Ehtenacher B, Weich HA. VEGF/Flk-1 interaction a reqirement for malignt aseites recurrence[ J].J Interfer Cyto Res,2000,20(4) :511-517.
  • 6Yoshiji H, Kuriyama S, Hicklin DJ, et al. The vascular endothelial growth factor receptor KDR/Flk-1 is a major regulator of malignant ascites formation in the mouse hepatocellular carinoma model [ J ].Hepatology,2001,33(7) :841-847.
  • 7高鹏,吴爱国,王宇,杨继震.大肠癌组织微血管密度和血管内皮生长因子表达的研究[J].中华实验外科杂志,2000,17(4):306-307. 被引量:7
  • 8赵建军,胡敬群,蔡建强,杨晓洁,杨治华.血管内皮生长因子在肝细胞癌血清中的表达意义[J].中华肿瘤杂志,2001,23(5):389-392. 被引量:19

二级参考文献3

共引文献24

同被引文献57

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部